EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib

Neuro-oncology
Shinji ShimatoJun Yoshida

Abstract

Gefitinib--a specific inhibitor of epidermal growth factor receptor (EGFR)-associated tyrosine kinase--has demonstrated efficacy in a subgroup of patients with non-small-cell lung carcinoma (NSCLC) who fail conventional chemotherapy. It is also reported to have an antitumor effect in brain metastases from NSCLC. Additionally, EGFR mutations have shown a strong association with gefitinib sensitivity for NSCLC. Here, we assessed the efficacy of gefitinib in brain metastases from NSCLC and evaluated the association of this efficacy with EGFR mutations. We retrospectively reviewed eight cases in which patients were suffering from brain metastases before the initiation of gefitinib treatment. Brain tumor response could be evaluated by MRI in these patients; EGFR gene analyses were also available. We evaluated whether objective tumor response was observed after gefitinib treatment and assessed the efficacy of gefitinib as effective, noneffective, or not assessable in consideration of the influence of previous radiotherapy. Of the eight patients, the efficacy of gefitinib was assessed as effective in three and as noneffective in three. All three patients demonstrating effective efficacy had EGFR mutations in the tyrosine kinase domain...Continue Reading

References

May 1, 1989·Archives of Internal Medicine·M P Merchut
Jul 1, 1997·International Journal of Radiation Biology·C S ChiangW H McBride
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federico CappuzzoLucio Crino
Jul 18, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·David H Johnson
Jul 18, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·David H Johnson
Jul 23, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Federico CappuzzoLucio Crinò
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Ke LiangZhen Fan
Oct 3, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J van den Bent
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin H CohenRichard Pazdur
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kathleen NevilleSusan M Blaney
Apr 28, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HaringhuizenN van Zandwijk
May 29, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hidenori TakahashiHidetada Sasaki
Jun 19, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G L CeresoliE Villa
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Oct 7, 2004·Trends in Molecular Medicine·Adi F GazdarJohn D Minna
Oct 8, 2004·Internal Medicine·Atsuko IshidaTeruomi Miyazawa
Oct 12, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Katsuyuki HottaMitsune Tanimoto
Nov 13, 2004·Oncology·Annette N Y PoonTony S K Mok
Nov 24, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Wolfgang Schuette
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tetsuya MitsudomiYasushi Yatabe

❮ Previous
Next ❯

Citations

Nov 11, 2011·Current Oncology Reports·Eugene Koay, Erik P Sulman
Jun 27, 2008·Current Treatment Options in Neurology·April F Eichler, Scott R Plotkin
Jul 23, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shih-Hsin HsiaoChi-Li Chung
Aug 11, 2006·Nature Biotechnology·Nickolas PapadopoulosBert Vogelstein
Sep 28, 2007·Nature Clinical Practice. Oncology·Minggui PanDavid B Wollman
Jul 24, 2012·Current Opinion in Oncology·Riccardo SoffiettiRoberta Rudà
Jul 5, 2007·Neurosurgical Focus·Robert Cavaliere, David Schiff
Nov 22, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Zhengbo Song, Yiping Zhang
Dec 7, 2013·Expert Review of Anticancer Therapy·Enrico FranceschiAlba A Brandes
Aug 21, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Tatsuya KatayamaTetsuya Mitsudomi
May 19, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yosuke TogashiMichiaki Mishima
Mar 5, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Lars Arne BergerDjordje Atanackovic
Aug 1, 2012·Clinical Lung Cancer·Jing ZhaoMengzhao Wang
May 7, 2011·Revue neurologique·O BailonA-F Carpentier
Nov 27, 2010·Neurosurgery Clinics of North America·Nicholas Butowski
Nov 27, 2010·Neurosurgery Clinics of North America·Muhammad M Abd-El-BarrGanesh Rao
Sep 17, 2009·Seminars in Oncology·Riccardo SoffiettiAnne Constanze Regierer
Mar 18, 2009·International Journal of Radiation Oncology, Biology, Physics·Joline S W LindSuresh Senan
Dec 19, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shenglin MaXinmin Yu
Jul 15, 2016·Journal of Medicinal Chemistry·Timothy P Heffron
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xuling Lin, Lisa M DeAngelis
Jan 24, 2013·International Journal of Molecular Sciences·Maria CaffoFrancesco Tomasello
Dec 1, 2017·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R F YangZ M Jiang
Nov 3, 2006·Expert Review of Neurotherapeutics·Jan Drappatz, Patrick Y Wen
Apr 17, 2012·Expert Review of Anticancer Therapy·Enrico Franceschi, Alba A Brandes
Dec 20, 2012·Expert Review of Anticancer Therapy·Marco BartolottiAlba Ariela Brandes
Aug 4, 2007·The Oncologist·April F Eichler, Jay S Loeffler
Nov 30, 2011·Current Opinion in Supportive and Palliative Care·May N TsaoMinesh P Mehta
Oct 23, 2012·Journal of Neuro-oncology·Fanny Burel-VandenbosFlorence Pedeutour
Nov 18, 2010·Expert Review of Anticancer Therapy·Yvonne Kienast, Frank Winkler
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alberto BroniscerClinton F Stewart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Chi WuZhong Wei
Annals of Oncology : Official Journal of the European Society for Medical Oncology
Giovanni L CeresoliE Villa
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Katsuyuki HottaMitsune Tanimoto
© 2021 Meta ULC. All rights reserved